Data for: Effect of trimethoxy flavones on paclitaxel - induced peripheral neuropathy in mice
收藏官方服务：
资源简介：
Statistical data of the above entitled study for the reference
应用场景：
创建时间：
2018-04-22
相关数据集
RNAseq highlights the role of Sirt2 in protecting neuronal cell from cisplatin-treated injury. RNAseq highlights the role of Sirt2 in protecting neuronal cell from cisplatin-treated injury
Background: Cisplatin is a common and effective chemotherapeutic agent used to treat various cancers. However, it has a dose-limiting effect, resulting in chemotherapy-induced peripheral neuropathy (C
NIAID Data Ecosystem70
Extracellular vesicle proteome of breast cancer patients with and without cognitive impairment following anthracycline-based chemotherapy
Cognitive impairment due to cancer and its therapy is a major concern among cancer survivors. Extracellular vesicles (EVs) composition altered by cancer and chemotherapy may affect neurological proces
NIAID Data Ecosystem40
Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinion
Chemotherapy-induced peripheral neurotoxicity (CIPN) remains a significant toxicity in cancer survivors without preventative strategies or rehabilitation. Exercise and physical activity-based interven
DataCite Commons2022-01-31 更新40
Gene expression signatures of chemotherapy-induced neuropathy induced by cisplatin and oxaliplatin. Gene expression signatures of chemotherapy-induced neuropathy induced by cisplatin and oxaliplatin
Vincristine, oxaliplatin, and cisplatin are commonly prescribed chemotherapeutic agents for the treatment of several cancer types. However, a main side-effect is chemotherapy-induced peripheral neurop
NIAID Data Ecosystem60
Table_1_Rationale and design of the prevention of paclitaxel-related neurological side effects with lithium trial – Protocol of a multicenter, randomized, double-blind, placebo- controlled proof-of-concept phase-2 clinical trial.DOCX
IntroductionChemotherapy-induced polyneuropathy (CIPN) and post-chemotherapy cognitive impairment (PCCI) are frequent side effects of paclitaxel treatment. CIPN/PCCI are potentially irreversible, redu
NIAID Data Ecosystem40
